Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brasso

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Biomedicines|March 29, 2023
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid ReviewClaudio Brasso, Gianluca Colli, Rodolfo Sgro, et al.
Journal of Clinical Medicine|February 25, 2023
Alteration of the Functional Connectivity of the Cortical Areas Characterized by the Presence of Von Economo Neurons in Schizophrenia, a Pilot StudyClaudio Brasso, Mario Stanziano, Francesca Marina Bosco, et al.
Journal of Clinical Medicine|November 25, 2023
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient's Subjective Quality of Life, Well-Being, and SatisfactionClaudio Brasso, Silvio Bellino, Paola Bozzatello, et al.
Neuropharmacology|January 22, 2018
Conditional inactivation of Npy1r gene in mice induces behavioural inflexibility and orbitofrontal cortex hyperactivity that are reversed by escitalopramAngela Longo, Melissa Fadda, Claudio Brasso, et al.
Frontiers in Psychiatry|November 26, 2025
An observational feasibility study on the impact of green exposure on major depressive episode symptomatology and inflammatory biomarkersGianna Pavarino, Claudio Brasso, Marina Boido, et al.
Neuroscience and Biobehavioral Reviews|January 26, 2021
Updating and characterizing neuroanatomical markers in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysisDonato Liloia, Claudio Brasso, Franco Cauda, et al.
Psychological Medicine|February 23, 2026
Identification of a diagnosis-selective neurobiological substrate for bipolar disorder, major depressive disorder, and schizophrenia: a meta-analysis of 57,717 subjectsDonato Liloia, Paola Rocca, Claudio Brasso, et al.
Frontiers in Psychiatry|June 28, 2024
<i>Omics</i> approaches open new horizons in major depressive disorder: from biomarkers to precision medicineFabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Brain, Behavior, & Immunity - Health|January 29, 2025
Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment responseFabiola Stolfi, Claudio Brasso, Davide Raineri, et al.
Schizophrenia Research|January 15, 2022
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophreniaLinda A Antonucci, Leonardo Fazio, Giulio Pergola, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Biomedicines|March 29, 2023
Efficacy of Serotonin and Dopamine Activity Modulators in the Treatment of Negative Symptoms in Schizophrenia: A Rapid ReviewClaudio Brasso, Gianluca Colli, Rodolfo Sgro, et al.
Journal of Clinical Medicine|February 25, 2023
Alteration of the Functional Connectivity of the Cortical Areas Characterized by the Presence of Von Economo Neurons in Schizophrenia, a Pilot StudyClaudio Brasso, Mario Stanziano, Francesca Marina Bosco, et al.
Journal of Clinical Medicine|November 25, 2023
Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient's Subjective Quality of Life, Well-Being, and SatisfactionClaudio Brasso, Silvio Bellino, Paola Bozzatello, et al.
Neuropharmacology|January 22, 2018
Conditional inactivation of Npy1r gene in mice induces behavioural inflexibility and orbitofrontal cortex hyperactivity that are reversed by escitalopramAngela Longo, Melissa Fadda, Claudio Brasso, et al.
Frontiers in Psychiatry|November 26, 2025
An observational feasibility study on the impact of green exposure on major depressive episode symptomatology and inflammatory biomarkersGianna Pavarino, Claudio Brasso, Marina Boido, et al.
Neuroscience and Biobehavioral Reviews|January 26, 2021
Updating and characterizing neuroanatomical markers in high-risk subjects, recently diagnosed and chronic patients with schizophrenia: A revised coordinate-based meta-analysisDonato Liloia, Claudio Brasso, Franco Cauda, et al.
Psychological Medicine|February 23, 2026
Identification of a diagnosis-selective neurobiological substrate for bipolar disorder, major depressive disorder, and schizophrenia: a meta-analysis of 57,717 subjectsDonato Liloia, Paola Rocca, Claudio Brasso, et al.
Frontiers in Psychiatry|June 28, 2024
<i>Omics</i> approaches open new horizons in major depressive disorder: from biomarkers to precision medicineFabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Brain, Behavior, & Immunity - Health|January 29, 2025
Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment responseFabiola Stolfi, Claudio Brasso, Davide Raineri, et al.
Schizophrenia Research|January 15, 2022
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophreniaLinda A Antonucci, Leonardo Fazio, Giulio Pergola, et al.
Pageof 4